About Legacy Pharma
Legacy Pharma is a company based in George Town, Grand Cayman. It operates as a Reseller / Distribution. Legacy Pharma has completed 1 acquisition, including InterMune. Legacy Pharma offers products and services including Betapace and Zanaflex.
- Headquarter George Town, Grand Cayman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Legacy Pharma
Legacy Pharma offers a comprehensive portfolio of products and services, including Betapace and Zanaflex.
Betapace is used to treat life-threatening ventricular arrhythmias.
Zanaflex is used to manage spasticity in patients.
People of Legacy Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Legacy Pharma
Detailed funding history for Legacy Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Legacy Pharma
Legacy Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include InterMune.
Investment portfolio details for Legacy Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies in pulmonology and orphan fibrotic diseases.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for Legacy Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Legacy Pharma
Detailed financials for Legacy Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Legacy Pharma Comparisons
Peer comparison for Legacy Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Legacy Pharma
Detailed competitors of Legacy Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Legacy Pharma
Complete news archive for Legacy Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Legacy Pharma
Legacy Pharma Inc. SEZC is involved in the distribution of established prescription pharmaceutical products. The company focuses on ensuring that in-demand brands remain accessible to patients who require them. Operations are conducted in the healthcare sector, specifically targeting the availability of critical medications for various conditions. Solutions are provided through a portfolio of products addressing arrhythmias, spasticity, and other medical needs.
Legacy Pharma offers Betapace and Zanaflex.
Legacy Pharma has made 1 acquisition, including InterMune.